Silence Therapeutics News

Silence Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(16.9%),Ora Capital Limited(7.8%)

Mar 27 17:10 ET

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lombard Odier Asset Management (USA) Corp(10.4%)

Feb 14 09:57 ET

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(5.43%),Deep Track Biotechnology Master Fund, Ltd.(5.43%), etc.

Feb 14 08:57 ET

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(2.2 %),GOLDMAN SACHS & CO. LLC(2.2 %)

Feb 12 18:20 ET

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(7.8%),Invus Public Equities Advisors, LLC(7.8%), etc.

Feb 9 17:10 ET

Silence Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Invus Public Equities, L.P.(6.8%),Invus Public Equities Advisors, LLC(6.8%), etc.

Sep 1, 2023 16:12 ET

Silence Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(26.58%)

Aug 14, 2023 17:01 ET

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(5.9%),TCG Crossover Fund I, L.P.(5.9%), etc.

Feb 14, 2023 14:23 ET

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lombard Odier Asset Management (USA) Corp(10.8%)

Feb 14, 2023 10:45 ET

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(5.1 %),GOLDMAN SACHS & CO. LLC(5.1 %)

Feb 8, 2023 15:09 ET

Silence Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(25.42%)

Oct 20, 2022 16:01 ET

Silence Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%), etc.

Aug 22, 2022 16:13 ET

Silence Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover Management, LLC(5.9%)

Aug 19, 2022 16:30 ET

Silence Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Ian Griffiths(28.4%)

Jul 20, 2022 16:00 ET

Silence Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Richard Ian Griffiths(27.0%)

Jun 15, 2022 16:31 ET

Silence Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Robert Quested(7.81%)

Feb 14, 2022 16:57 ET

Silence Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Richard Ian Griffiths(23.05%)

Feb 14, 2022 16:54 ET

Silence Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lombard Odier Asset Management (USA) Corp(11.6%)

Feb 10, 2022 16:44 ET

Silence Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mallinckrodt plc(5.64%),Cache Holdings Limited(5.64%)

Feb 7, 2022 16:01 ET

Silence Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(5.4 %),GOLDMAN SACHS & CO. LLC(5.4 %)

Jan 27, 2022 14:51 ET